Literature DB >> 7964634

Identification, sequencing and expression of the glycoprotein L gene of murine cytomegalovirus.

J Xu1, A A Scalzo, P A Lyons, H E Farrell, W D Rawlinson, G R Shellam.   

Abstract

DNA sequence analysis of the genome of the Smith strain of murine cytomegalovirus (MCMV) revealed an open reading frame (ORF) with amino acid sequence identity to glycoprotein L (gL) of other herpesviruses. The ORF is 822 bp in size and has the capacity to encode a protein of 274 amino acids. It has significant identity with the gL genes of human CMV and human herpesvirus 6. The coding sequence of the gL gene of MCMV strain K181 was also determined, and expressed in Escherichia coli as a fusion protein with glutathione S-transferase using the pGEX expression system. Two antibody-binding regions were identified on the basis of the reactivity of a series of truncated gL constructs with anti-MCMV antibodies. One was mapped to residues 1 to 38 and the other between residues 230 and 274. Polyclonal antibodies specific to gL were raised against the full-length gL fusion protein. The antisera were shown to react with a 46K protein present in purified virions by Western blotting. Treatment of purified virions with endoglycosidase-H or -F resulted in reductions in M(r) of the 46K species to 42K and 31K, respectively. The antisera did not exhibit any neutralizing activity in a plaque reduction assay.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964634     DOI: 10.1099/0022-1317-75-11-3235

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth.

Authors:  A Angulo; P Ghazal; M Messerle
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H.

Authors:  B G Klupp; W Fuchs; E Weiland; T C Mettenleiter
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism.

Authors:  V J Cavanaugh; R M Stenberg; T L Staley; H W Virgin; M R MacDonald; S Paetzold; H E Farrell; W D Rawlinson; A E Campbell
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination.

Authors:  Helen E Farrell; Nick Davis-Poynter; Kimberley Bruce; Clara Lawler; Lars Dolken; Michael Mach; Philip G Stevenson
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

5.  Analysis of the complete DNA sequence of murine cytomegalovirus.

Authors:  W D Rawlinson; H E Farrell; B G Barrell
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Sayoko Yonemoto; Masato Koike; Masaya Takemoto; Tomohiko Sadaoka; Yumi Sasamoto; Shozo Konishi; Yasuo Uchiyama; Koichi Yamanishi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Identification of proteins associated with murine cytomegalovirus virions.

Authors:  Lisa M Kattenhorn; Ryan Mills; Markus Wagner; Alexandre Lomsadze; Vsevolod Makeev; Mark Borodovsky; Hidde L Ploegh; Benedikt M Kessler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Xuwei Yang; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes.

Authors:  Paul Lacaze; Thorsten Forster; Alan Ross; Lorraine E Kerr; Eliane Salvo-Chirnside; Vanda Juranic Lisnic; Guillermo H López-Campos; José J García-Ramírez; Martin Messerle; Joanne Trgovcich; Ana Angulo; Peter Ghazal
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.